A Study on the Effects of Breathing Exercises and Aerobic Exercise on the Health of Men in Drug Rehabilitation
2026년 5월 11일 업데이트: Yongting Li, Southwest Medical University
A Study on the Effects of 8 Weeks of Resistance and Respiratory Training Combined With Aerobic Exercise on Physical Health and Quality of Life in Male Drug Rehabilitation Patients
This study aims to investigate the effects of an 8-week combined exercise program on male individuals in drug rehabilitation.
The program integrates resistance-based breathing training with aerobic exercise.
The investigators seek to determine whether this combined exercise program is more effective than a single form of exercise in improving participants' physical health and quality of life.
The primary research questions to be addressed include: Does this combined exercise program produce better results than single-form training (resistance-based breathing training or aerobic exercise performed separately) in improving physiological indicators such as cardiopulmonary function and muscle strength in male individuals in drug rehabilitation?
Does this combined exercise program yield greater benefits than single-form training in reducing anxiety and depression and improving quality of life among men in drug rehabilitation?
This study will conduct a randomized controlled trial.
Researchers will compare three different intervention groups-the combined training group, the resistance-breathing training group, and the aerobic exercise group-to verify the potential advantages of the combined program over single-form exercise.
Participants will: Complete an 8-week exercise intervention, consisting of three sessions per week, each lasting approximately 40 minutes, under professional guidance and supervision.
Undergo comprehensive assessments before and after the intervention, including cardiopulmonary function tests, body composition analysis, and questionnaires on mental health and quality of life.
연구 개요
상태
모병
상세 설명
- Exploration and Standardization of a Combined Exercise Program Tailored for Drug Rehabilitation Facilities. This section forms the foundation of the study and aims to develop an 8-week combined exercise program that is safe, effective, and easy to implement, specifically tailored to the environment and characteristics of residents in compulsory isolation drug rehabilitation centers. The content not only covers specific methods for integrating resistance-based breathing exercises with aerobic exercises (such as sequence, frequency, intensity, and duration) but also focuses on designing standardized operating procedures. These include concise instructions for participants, demonstration videos, key safety monitoring points (such as using the Borg Subjective Fatigue Scale or heart rate monitoring), and contingency plans for addressing common issues. The goal is to produce a "ready-to-use" guidebook that lays a solid foundation for subsequent implementation.
- Empirical Validation and Comparison of the Combined Exercise Program's Efficacy. This section constitutes the core of the study, aiming to empirically validate the actual effectiveness of this combined program for male individuals in the drug rehabilitation phase through a randomized controlled trial. Effectiveness evaluation will be entirely centered on the application objectives. It will primarily include: ① Physical Health: Focusing on verifying its effectiveness in improving areas of weakness among drug rehabilitation participants, such as cardiopulmonary function, muscle strength, and body composition; ② Mental Health and Quality of Life: Focusing on its positive impact on core rehabilitation goals such as anxiety and depression, sleep quality, and drug craving. The investigators will employ a controlled design with a combined-training group and a single-training group to address a key practical question: Does this combined program produce a "1+1>2" synergistic effect compared with single-modality resistance-breathing training or aerobic exercise, thereby offering greater practical value?
연구 유형
중재적
등록 (추정된)
90
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 장소
-
-
-
Luzhou, 중국, 646000
- 모병
- Yongtingli
-
연락하다:
- Yongting Li
- 전화번호: 18226377721
- 이메일: 18226377721@163.com
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
예
설명
Inclusion Criteria:
- Male, aged 18 to 50 years, able to understand and comply with the study protocol
- Meets the DSM-5 diagnostic criteria for substance use disorder; in rehabilitation for ≥1 month; withdrawal symptoms are stable (confirmed by medical staff)
- No severe cardiovascular/cerebrovascular disease, respiratory disease, musculoskeletal injury, or other contraindications to physical activity
- Basic reading and writing ability to independently complete questionnaire assessments
- Voluntarily signed informed consent and committed to complying with the 8-week training program
Exclusion Criteria：
- Presence of contraindications to exercise (e.g., recent fracture, severe arrhythmia, uncontrolled hypertension)
- Concurrent severe mental disorders (e.g., schizophrenia, acute depressive episode) or currently receiving unstable psychiatric medication
- Currently participating in other intervention studies or clinical trials
- Expected training compliance rate <70% (e.g., unable to complete the 8-week intervention due to transfer or disciplinary action)
- Unable to continue participation for personal reasons (e.g., early discharge, serious disciplinary violation)
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Resistance Breathing Training Group
Use a resistance breathing trainer and follow a progressive resistance training regimen, starting with low resistance and gradually increasing the intensity based on individual tolerance.
|
Warm-up (5 minutes) → Threshold resistance breathing trainer (30 minutes) → Cool-down stretches (5 minutes).During joint training, each session lasts 15 minutes.
다른 이름들:
|
|
실험적: Aerobic Exercise Group
This session features moderate-intensity aerobic exercise, with intensity maintained at 60-70% of maximum heart rate, and includes a warm-up, main workout, and cool-down.
|
Warm-up (5 minutes) → Main exercise (30 minutes, at 65%-85% of maximum heart rate or a Borg RPE score of 12-14) → Cool-down and stretching (5 minutes).During joint training sessions, each training session lasts 15 minutes.
다른 이름들:
|
|
실험적: Joint Training Group
After the warm-up, start with 15 minutes of resistance breathing exercises, followed by 15 minutes of aerobic exercise, and then five minutes of stretching.
|
Warm-up (5 minutes) → Threshold resistance breathing trainer (30 minutes) → Cool-down stretches (5 minutes).During joint training, each session lasts 15 minutes.
다른 이름들:
Warm-up (5 minutes) → Main exercise (30 minutes, at 65%-85% of maximum heart rate or a Borg RPE score of 12-14) → Cool-down and stretching (5 minutes).During joint training sessions, each training session lasts 15 minutes.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Quality of Life Scale for Drug Addicts
기간: Baseline (Week 0), after the intervention (Week 9)
|
Minimum score: 41, Maximum score: 205.Higher scores indicate worse quality of life and more severe impairment in physical, psychological, social, and withdrawal-related symptoms.
|
Baseline (Week 0), after the intervention (Week 9)
|
|
6-Minute Walk Test
기간: Baseline (Week 0), after the intervention (Week 9)
|
The maximum distance a subject can cover in 6 minutes while walking at maximum speed along a 30-meter flat corridor.
This test is used to assess cardiopulmonary function and exercise endurance during submaximal exercise.
|
Baseline (Week 0), after the intervention (Week 9)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
BMI
기간: Baseline (Week 0), after the intervention (Week 9)
|
Weight (kg) and height (m) will be combined and reported as BMI, expressed in kg/m²
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Body Composition
기간: Baseline (Week 0), after the intervention (Week 9)
|
Data was measured and analyzed using bioelectrical impedance analysis (BIA) with a body composition analyzer (MC-780MA, TANITA), including: body fat mass, skeletal muscle mass, body water, visceral fat, and basal metabolic rate.
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Symptom Checklist-90
기간: Baseline (Week 0), after the intervention (Week 9)
|
Symptom Checklist-90 (SCL-90); range 90-450; higher scores = worse mental health.
Dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, sleep and eating.
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Vital Capacity
기간: Baseline (Week 0), after the intervention (Week 9)
|
A spirometer is used to measure the maximum volume of air a subject can exhale after taking a deep breath.
This measurement is used to assess lung ventilation function.
The unit of measurement is milliliters (mL).
|
Baseline (Week 0), after the intervention (Week 9)
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Blood pressure
기간: Baseline (Week 0), after the intervention (Week 9)
|
Unit: mmHg; Abnormal value = Poor cardiovascular health
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Oxygen Saturation
기간: Baseline (Week 0), after the intervention (Week 9)
|
The percentage of peripheral blood oxygen saturation measured using a pulse oximeter at rest.
Used to assess the body's oxygenation status and respiratory efficiency.
Unit: %
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Resting heart rate
기간: Baseline (Week 0), after the intervention (Week 9)
|
The unit is "beats per minute (bpm)"; measurements are taken using standard heart rate monitoring equipment while the subject is at rest, and are used to assess baseline cardiovascular function.
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Peak expiratory flow
기간: Baseline (Week 0), after the intervention (Week 9)
|
The peak expiratory flow rate, measured in liters per minute using a spirometer during a forced exhalation, directly reflects airway patency and respiratory muscle strength; a higher value indicates better respiratory function.
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Visual Analogue Scale for Drug Craving
기간: Baseline (Week 0), after the intervention (Week 9)
|
Visual Analogue Scale for Drug Craving (VAS)Minimum score: 0, Maximum score: 10.Higher scores indicate more severe drug craving.
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Grip strength
기간: Baseline (Week 0), after the intervention (Week 9)
|
Grip strength (kg): The maximum grip force measured using a handheld dynamometer, used to assess upper body strength.
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Back Scratch Test
기간: Baseline (Week 0), after the intervention (Week 9)
|
Shoulder joint range of motion and upper limb flexibility are assessed by measuring the distance between the middle fingers when the hands are placed as close together as possible behind the back.
The unit is centimeters (cm); a negative value indicates that the fingers overlap, while a positive value indicates that they do not overlap.
|
Baseline (Week 0), after the intervention (Week 9)
|
|
Number of repetitions in the 30-second chair stand test
기간: Baseline (Week 0), after the intervention (Week 9)
|
The maximum number of times a person can stand up completely from a standard chair and sit back down within 30 seconds, used to assess lower limb function
|
Baseline (Week 0), after the intervention (Week 9)
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
2026년 4월 1일
기본 완료 (추정된)
2026년 6월 10일
연구 완료 (추정된)
2026년 6월 30일
연구 등록 날짜
최초 제출
2026년 4월 28일
QC 기준을 충족하는 최초 제출
2026년 5월 11일
처음 게시됨 (실제)
2026년 5월 18일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2026년 5월 18일
QC 기준을 충족하는 마지막 업데이트 제출
2026년 5월 11일
마지막으로 확인됨
2026년 4월 1일
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- SWMUIRBTX-202603-0015
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
아니요
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
아니
미국 FDA 규제 기기 제품 연구
아니
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .